2-(o-tolyloxymethyl)-2,3-dihydrobenzo[b][1,4]dioxine | 1049011-39-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并二恶烷
• 英文名称: 2-(o-tolyloxymethyl)-2,3-dihydrobenzo[b][1,4]dioxine
• 英文别名: 2-(o-tolyloxymethyl)-2,3-dihydrobenzo[1,4]dioxine；2-[(2-Methylphenoxy)methyl]-2,3-dihydro-1,4-benzodioxine；3-[(2-methylphenoxy)methyl]-2,3-dihydro-1,4-benzodioxine
• CAS: 1049011-39-3
• 化学式: C₁₆H₁₆O₃
• 分子量: 256.301
• InChiKey: KTENNJKXILZIRY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-[(2-碘苯氧基)甲基]环氧乙烷 、 邻甲酚 在 1,10-菲罗啉 、 caesium carbonate 、 copper(I) bromide 作用下， 以 N,N-二甲基乙酰胺 为溶剂， 反应 48.0h， 以73%的产率得到2-(o-tolyloxymethyl)-2,3-dihydrobenzo[b][1,4]dioxine
  参考文献：
  名称：

  Copper-catalyzed tandem process: an efficient approach to 2-substituted-1,4-benzodioxanes

  摘要：

  一种高效的方法已被开发，用于通过CuBr催化的串联反应，将2-((o-碘苯氧基)methyl)环氧烷与酚类化合物制备多种2-取代-1,4-苯并二恶烷。该反应涉及2-((2-碘苯氧基)methyl)环氧烷的开环过程，随后进行分子内C–O交叉耦合环化反应。

  DOI：

  10.1039/c003691a

文献信息

• THIOXOTHIAZOLIDINE DERIVATIVE HAVING RAS FUNCTION INHIBITORY EFFECT
  申请人：Kataoka Tohru

  公开号：US20140194412A1

  公开（公告）日：2014-07-10

  The present invention provides an anticancer drug having a Ras function inhibitory action. The present invention provides a Ras function inhibitor comprising a compound represented by the formula (I′): wherein each symbol is as defined in the present specification, or a salt thereof.

  本发明提供一种具有Ras功能抑制作用的抗癌药物。 本发明提供一种包括由式(I′)表示的化合物的Ras功能抑制剂： 其中每个符号如本说明书中所定义，或其盐。
• AZOLYLMETHYLIDENEHYDRAZINE DERIVATIVE AND USE THEREOF
  申请人：Ogura Hironobu

  公开号：US20100190754A1

  公开（公告）日：2010-07-29

  An azolylmethylidenehydrazine derivative represented by the formula (I) wherein Ar is an aryl group optionally having substituent(s) or a heteroaryl group optionally having substituent(s), R 1 and R 2 are the same or different and each is an alkyl group, a cycloalkyl group, an aralkyl group optionally having substituent(s), an aryl group optionally having substituent(s), a heteroarylalkyl group optionally having substituent(s), or R 1 and R 2 are bonded to each other to form a nitrogen-containing heterocyclic group optionally having substituent(s), and X is CH or a nitrogen atom, or a pharmacologically acceptable salt thereof is useful as a medicament, particularly as an antifungal agent, or an anti-inflammatory agent or an antiallergic agent.

  一种以式(I)表示的氮杂环甲基亚唑啉衍生物，其中Ar是一个芳基基团，可选择地具有取代基，或者是一个杂芳基基团，可选择地具有取代基；R1和R2相同或不同，每个都是一个烷基基团、环烷基基团、可选择地具有取代基的芳基烷基基团、可选择地具有取代基的芳基基团、可选择地具有取代基的杂芳基烷基基团，或者R1和R2彼此连接形成一个可选择地具有取代基的含氮杂环基团；X是CH或氮原子；或其药学上可接受的盐，可用作药物，特别是作为抗真菌药物、抗炎药物或抗过敏药物。
• AZOLYLMETHYLENEHYDRAZINE DERIVATIVE AND USE THEREOF
  申请人：KAKEN PHARMACEUTICAL CO., LTD.

  公开号：EP2168951A1

  公开（公告）日：2010-03-31

  An azolylmethylidenehydrazine derivative represented by the formula (I) wherein Ar is an aryl group optionally having substituent(s), a heteroaryl group optionally having substituent(s) or a heteroaryl group optionally having substituent(s), R1 and R2 are the same or different and each is an alkyl group, a cycloalkyl group, an aralkyl group optionally having substituent(s), an aryl group optionally having substituent(s), a heteroarylalkyl group optionally having substituent(s), or R1 and R2 are bonded to each other to form a nitrogen-containing heterocyclic group optionally having substituent(s), and X is CH or a nitrogen atom, or a pharmacologically acceptable salt thereof is useful as a medicament, particularly as an antifungal agent, or an anti-inflammatory agent or an antiallergic agent.

  由式 (I) 代表的偶氮亚甲基肼衍生物 其中 Ar 是可选具有取代基的芳基、可选具有取代基的杂芳基或可选具有取代基的杂芳基、 R1 和 R2 相同或不同，且各自为烷基、环烷基、任选具有取代基的芳烷基、任选具有取代基的芳基、任选具有取代基的杂芳基，或 R1 和 R2 相互键合形成任选具有取代基的含氮杂环基，且 X 为 CH 或氮原子、 或其药理上可接受的盐可用作药物，特别是抗真菌剂、抗炎剂或抗过敏剂。
• Cu₂O-Catalyzed Tandem Ring-Opening/Coupling Cyclization Process for the Synthesis of 2,3-Dihydro-1,4-benzodioxins
  作者：Weiliang Bao、Yunyun Liu、Xin Lv、Weixing Qian

  DOI：10.1021/ol801444p

  日期：2008.9.1

  2, 3-Dihydro-1,4-benzodioxins can be prepared in a tandem one-pot procedure by reaction of o-iodophenols with epoxides catalyzed by Cu2O/1,10-phenanthroline/Cs2CO3 system. The reaction is suggested to occur via a novel ring-opening/coupling mechanism, giving moderate to good yields. Moreover, both aryl and aliphatic epoxides are tolerated under these conditions.
• NOUVELLES CYANOGUANIDINES, LEUR PROCEDE D'OBTENTION ET LES COMPOSITIONS PHARMACEUTIQUES EN RENFERMANT
  申请人：BOUCHARA S.A.

  公开号：EP0105881B1

  公开（公告）日：1987-12-23